New Patient-Oriented Tools for Assessing Atrophic Acne Scarring.

ABSTRACT:

Introduction

Scarring on visible areas such as the face is associated with negative psychological impact. Many patients with acne have clinically relevant scarring for which they seek treatment, implying that there is an impact on their lives. Currently there are no validated tools to assess the burden of atrophic acne scarring from the patient's perspective or to assess treatment benefit.

Methods

Two patient-reported outcome measures, the self-assessment of clinical acne-related scars (SCARS) and the facial acne scar quality of life (FASQoL) tools, both specific to facial atrophic acne scarring, were developed according to Food and Drug Administration guidance methodology. Patient interviews were conducted first to elicit patient-important concepts about scarring, then to v

SUBMITTER: Layton A 

PROVIDER: S-EPMC4906116 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature